PRESS RELEASE
Jul 01, 2026
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
Jul 01, 2026
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
Jun 16, 2026
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
Jun 12, 2026
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
Jun 10, 2026
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ(TM), a Biological Context Layer for AI Drug Discovery
Dec 08, 2025
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
Dec 19, 2024
IPA to Present at The Microcap Conference 2025
Apr 22, 2024
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results
Apr 12, 2024
ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments
Mar 08, 2024
ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology